Andrew E Mulberg1. Show Affiliations » 1. Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ 08560, USA. AMulberg@PRDUS.JNJ.com
Abstract
Mesh： See more » ChildDrug Industry/trendsHumansIrritable Bowel Syndrome/drug therapyPediatrics/trendsUnited StatesUnited States Food and Drug Administration
Year: 2008 PMID： 18955888 DOI： 10.1097/01.mpg.0000338970.57088.89
Source DB: PubMed Journal: J Pediatr Gastroenterol Nutr ISSN： 0277-2116 Impact factor: 2.839